| Similar Articles |
|---|
 |
Fast Company
April 2004
Scott Kirsner |
Fantastic Voyage Cyberonics' medical implant is the size of a chocolate-chip cookie, and it could be worth $2.8 billion someday. But as this dramatic tale of innovation and entrepreneurship shows, saving lives can be one tough business.   |
IEEE Spectrum
May 2005
Samuel K. Moore |
Zapping Away The Blues Cyberonics Inc. plans to introduce the first implanted device that can treat a psychiatric illness. |
The Motley Fool
February 4, 2005
Stephen D. Simpson |
Cyberonics' Depression Zapper Medical technology company gets a much-needed boost from the FDA. |
The Motley Fool
June 16, 2004
W.D. Crotty |
Nothing Depressing Cyberonics Cyberonics Gets FDA nod; shareholder Boston Scientific gets a portfolio boost. |
IEEE Spectrum
October 2008
Samuel K. Moore |
U.S. Regulators Approve Magnetic Stimulation Device for Depression Neuronetics' repetitive transcranial magnetic stimulation wins long battle for FDA approval. Questions remain about whether insurers will pay for it |
The Motley Fool
February 8, 2005
Stephen D. Simpson |
Cyberonics Looks to the Future Shifting resources to the launch of a depression therapy will hurt now, but should pay off later. Investors looking to take on some risk in exchange for an aggressive growth opportunity might want to explore this one. |
The Motley Fool
November 22, 2005
Stephen D. Simpson |
Cyberonics' Ride Not Over Yet One way or another, this medical device maker's stock is almost certain to produce more volatility in the years to come. |
BusinessWeek
October 1, 2009 |
Stalking the Future J&J lost patent protection on epilepsy and schizophrenia drugs worth $7 billion last year. These new drugs, if cleared by the FDA, could help offset the damage. |
IEEE Spectrum
March 2006
Samuel K. Moore |
Psychiatry's Shocking New Tools Electronic implants and electromagnetic pulses are picking up where psychoactive drugs have failed. |
The Motley Fool
June 14, 2011
Frank Vinluan |
GSK Epilepsy Drug Approved by FDA GlaxoSmithKline and drug partner Valeant Pharmaceuticals have received U.S. Food and Drug Administration approval on a new epilepsy drug, but it must be classified as a controlled substance. |
American Family Physician
July 1, 2001 |
What Should I Know About Seizures and Epilepsy? What is a seizure, and what is epilepsy?... What causes epilepsy?... Who gets epilepsy?... Are all seizures the same?... How does the doctor find out I have epilepsy?... |
BusinessWeek
March 7, 2005
Michael Arndt |
Rewiring The Body First came pacemakers. Now exotic implants are bringing new hope to victims of epilepsy, paralysis, depression, and other diseases. And some of the biggest names in health care are in a scramble to get into the market. |
The Motley Fool
August 10, 2010
Brian Orelli |
When the Disease Matters Most in Drug Approval Glaxo's and Valeant's Potiga will go before an FDA advisory committee tomorrow. |
IEEE Spectrum
June 2009
Virginia Hughes |
A New Approach to Predicting Epileptic Seizures Torrents of data produced by implanted microelectrodes could finally yield a prediction system |
Pharmaceutical Executive
April 1, 2006
Jill Wechsler |
Washington Report: A Warning Trend Washington's new answer to drug safety concerns is more warnings and more disclosure of undigested data. But warnings can go too far. Haven't FDA's critics ever heard the story of the boy who cried wolf? |
BusinessWeek
March 7, 2005
Michael Arndt |
"Pacemakers" for the Rest of You Slews of tiny devices that deliver electrical stimulation to a wide variety of organs should soon become available. |
American Family Physician
September 15, 2002 |
Depression What is depression?... What causes depression?... How is depression diagnosed?... How is depression treated?... What about suicide?... |
American Family Physician
July 1, 2001
Selim R. Benbadis |
Advances in the Treatment of Epilepsy Significant advances have been made in the diagnosis and treatment of epilepsy over the past decade... |
AskMen.com
January 6, 2001
Joshua Levine |
Dealing With Depression Clinical depression is an illness characterized by a cluster of feelings, thoughts and behaviors that are strikingly different from a person's normal range of feeling and functioning... |
American Family Physician
September 1, 2000
Gary N. McAbee & James E. Wark |
A Practical Approach to Uncomplicated Seizures in Children Uncomplicated seizures and epilepsy are common in infants and children. Not all uncomplicated childhood seizures require neuroimaging or treatment... |
BusinessWeek
May 2, 2005
Kate Murphy |
Easing Depression Without Drugs Doctors are trying therapies, from implants to herbs, that can cut down on side effects. |
Pharmaceutical Executive
January 1, 2006
Michael Fronstin |
A Fresh Look at Co-morbidity You may think you understand a disease. But then it arrives in tandem. A new survey takes a fresh look at co-morbidity. |
BusinessWeek
June 26, 2006
Jane Sasseen |
Another Dodgy Way To Dole Out Options Grants intentionally timed to good news are becoming the focus of greater scrutiny. |
